CN106212614A - A kind of cookies of early prevention and treatment type 2 diabetes mellitus and preparation method thereof - Google Patents
A kind of cookies of early prevention and treatment type 2 diabetes mellitus and preparation method thereof Download PDFInfo
- Publication number
- CN106212614A CN106212614A CN201610775180.XA CN201610775180A CN106212614A CN 106212614 A CN106212614 A CN 106212614A CN 201610775180 A CN201610775180 A CN 201610775180A CN 106212614 A CN106212614 A CN 106212614A
- Authority
- CN
- China
- Prior art keywords
- semen
- radix
- medicine
- rhizoma
- cookies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000014510 cooky Nutrition 0.000 title claims abstract description 42
- 238000011282 treatment Methods 0.000 title claims abstract description 38
- 230000002265 prevention Effects 0.000 title claims abstract description 29
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 210000000582 semen Anatomy 0.000 claims abstract description 116
- 235000013305 food Nutrition 0.000 claims abstract description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 210000004369 blood Anatomy 0.000 claims description 122
- 239000008280 blood Substances 0.000 claims description 122
- 239000003814 drug Substances 0.000 claims description 95
- 235000005911 diet Nutrition 0.000 claims description 67
- 235000000346 sugar Nutrition 0.000 claims description 48
- 238000000034 method Methods 0.000 claims description 30
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 24
- 229940079593 drug Drugs 0.000 claims description 23
- 230000009467 reduction Effects 0.000 claims description 16
- 230000037213 diet Effects 0.000 claims description 15
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 8
- 210000002966 serum Anatomy 0.000 claims description 8
- 230000001413 cellular effect Effects 0.000 claims description 7
- 235000013312 flour Nutrition 0.000 claims description 7
- 238000007654 immersion Methods 0.000 claims description 6
- 229910052573 porcelain Inorganic materials 0.000 claims description 6
- 230000003405 preventing effect Effects 0.000 claims description 6
- 230000007306 turnover Effects 0.000 claims description 6
- 241000209140 Triticum Species 0.000 claims description 5
- 235000021307 Triticum Nutrition 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical group C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 claims description 4
- 241001107116 Castanospermum australe Species 0.000 claims description 4
- 235000021279 black bean Nutrition 0.000 claims description 4
- 239000003205 fragrance Substances 0.000 claims description 3
- 239000002304 perfume Substances 0.000 claims description 3
- 239000003507 refrigerant Substances 0.000 claims description 3
- 235000013599 spices Nutrition 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000009461 vacuum packaging Methods 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 abstract description 12
- 229920001282 polysaccharide Polymers 0.000 abstract description 12
- 239000005017 polysaccharide Substances 0.000 abstract description 12
- 239000000463 material Substances 0.000 abstract description 9
- 235000008935 nutritious Nutrition 0.000 abstract description 4
- 235000013376 functional food Nutrition 0.000 abstract description 3
- 230000000680 avirulence Effects 0.000 abstract description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 100
- 239000008103 glucose Substances 0.000 description 100
- 230000000694 effects Effects 0.000 description 60
- 230000000378 dietary effect Effects 0.000 description 52
- 238000002560 therapeutic procedure Methods 0.000 description 50
- 235000001727 glucose Nutrition 0.000 description 38
- 230000006870 function Effects 0.000 description 36
- 210000003734 kidney Anatomy 0.000 description 33
- 210000000952 spleen Anatomy 0.000 description 32
- 230000007812 deficiency Effects 0.000 description 27
- 206010012601 diabetes mellitus Diseases 0.000 description 27
- 235000012054 meals Nutrition 0.000 description 24
- 235000016709 nutrition Nutrition 0.000 description 22
- 210000002784 stomach Anatomy 0.000 description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 21
- 201000010099 disease Diseases 0.000 description 19
- 230000036772 blood pressure Effects 0.000 description 18
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 18
- 210000004072 lung Anatomy 0.000 description 18
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 17
- 239000003925 fat Substances 0.000 description 16
- 235000019197 fats Nutrition 0.000 description 16
- 230000002218 hypoglycaemic effect Effects 0.000 description 16
- 210000004185 liver Anatomy 0.000 description 16
- 238000002372 labelling Methods 0.000 description 15
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 14
- 230000003203 everyday effect Effects 0.000 description 14
- 230000035922 thirst Effects 0.000 description 14
- 239000011701 zinc Substances 0.000 description 14
- 229910052725 zinc Inorganic materials 0.000 description 14
- 235000016804 zinc Nutrition 0.000 description 14
- 206010012735 Diarrhoea Diseases 0.000 description 13
- 102000001554 Hemoglobins Human genes 0.000 description 12
- 108010054147 Hemoglobins Proteins 0.000 description 12
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 12
- 230000036541 health Effects 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 239000000796 flavoring agent Substances 0.000 description 11
- 235000019634 flavors Nutrition 0.000 description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 10
- 238000009826 distribution Methods 0.000 description 10
- 210000004209 hair Anatomy 0.000 description 10
- 229910052711 selenium Inorganic materials 0.000 description 10
- 239000011669 selenium Substances 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 102000004877 Insulin Human genes 0.000 description 9
- 108090001061 Insulin Proteins 0.000 description 9
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 9
- 229940024606 amino acid Drugs 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 9
- 229940125396 insulin Drugs 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 238000010791 quenching Methods 0.000 description 9
- 230000001225 therapeutic effect Effects 0.000 description 9
- 206010020772 Hypertension Diseases 0.000 description 8
- 208000005946 Xerostomia Diseases 0.000 description 8
- 208000002173 dizziness Diseases 0.000 description 8
- 206010013781 dry mouth Diseases 0.000 description 8
- 201000001421 hyperglycemia Diseases 0.000 description 8
- -1 lipid peroxide Chemical class 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 241000756042 Polygonatum Species 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 235000001465 calcium Nutrition 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 7
- 230000036039 immunity Effects 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 230000035764 nutrition Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 206010056997 Impaired fasting glucose Diseases 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 235000013325 dietary fiber Nutrition 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 229910052698 phosphorus Inorganic materials 0.000 description 6
- 239000011574 phosphorus Substances 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 210000002700 urine Anatomy 0.000 description 6
- 206010003210 Arteriosclerosis Diseases 0.000 description 5
- 235000002722 Dioscorea batatas Nutrition 0.000 description 5
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 5
- 240000001811 Dioscorea oppositifolia Species 0.000 description 5
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 5
- 208000011775 arteriosclerosis disease Diseases 0.000 description 5
- 235000013339 cereals Nutrition 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 229960003512 nicotinic acid Drugs 0.000 description 5
- 235000001968 nicotinic acid Nutrition 0.000 description 5
- 239000011664 nicotinic acid Substances 0.000 description 5
- 235000021590 normal diet Nutrition 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 239000011573 trace mineral Substances 0.000 description 5
- 235000013619 trace mineral Nutrition 0.000 description 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 208000002705 Glucose Intolerance Diseases 0.000 description 4
- 206010020710 Hyperphagia Diseases 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 239000005642 Oleic acid Substances 0.000 description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 206010038743 Restlessness Diseases 0.000 description 4
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 4
- 230000001142 anti-diarrhea Effects 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 229930003944 flavone Natural products 0.000 description 4
- 150000002212 flavone derivatives Chemical class 0.000 description 4
- 235000011949 flavones Nutrition 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 230000003914 insulin secretion Effects 0.000 description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 206010025482 malaise Diseases 0.000 description 4
- 239000000401 methanolic extract Substances 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- 208000022530 polyphagia Diseases 0.000 description 4
- 201000009104 prediabetes syndrome Diseases 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 230000001502 supplementing effect Effects 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 4
- 239000011800 void material Substances 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 3
- 229930182837 (R)-adrenaline Natural products 0.000 description 3
- 206010061623 Adverse drug reaction Diseases 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 3
- 201000000297 Erysipelas Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229920002527 Glycogen Polymers 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 240000005373 Panax quinquefolius Species 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 206010047513 Vision blurred Diseases 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 231100000360 alopecia Toxicity 0.000 description 3
- 230000001466 anti-adreneric effect Effects 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 239000002221 antipyretic Substances 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 150000001746 carotenes Chemical class 0.000 description 3
- 235000005473 carotenes Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000002490 cerebral effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 229960005139 epinephrine Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 235000014105 formulated food Nutrition 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 229930182478 glucoside Natural products 0.000 description 3
- 150000008131 glucosides Chemical class 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 2
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 108010075254 C-Peptide Proteins 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010019345 Heat stroke Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 241001448624 Miliaria Species 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- 235000009811 Momordica charantia Nutrition 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 244000078912 Trichosanthes cucumerina Species 0.000 description 2
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002908 adrenolytic effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 229940093797 bioflavonoids Drugs 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 238000009207 exercise therapy Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 150000002304 glucoses Chemical class 0.000 description 2
- 230000002641 glycemic effect Effects 0.000 description 2
- 230000034659 glycolysis Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 2
- 230000001926 lymphatic effect Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 2
- 229960003105 metformin Drugs 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 210000001589 microsome Anatomy 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 239000011733 molybdenum Substances 0.000 description 2
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 2
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 235000015500 sitosterol Nutrition 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 2
- 230000021595 spermatogenesis Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241000252229 Carassius auratus Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- PBAYDYUZOSNJGU-UHFFFAOYSA-N Chelidonic acid Chemical compound OC(=O)C1=CC(=O)C=C(C(O)=O)O1 PBAYDYUZOSNJGU-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 102000003914 Cholinesterases Human genes 0.000 description 1
- 108090000322 Cholinesterases Proteins 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 241001517488 Clavus Species 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000045500 Diseae Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 101150076104 EAT2 gene Proteins 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- SQFSKOYWJBQGKQ-UHFFFAOYSA-N Kaempferide Natural products C1=CC(OC)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 SQFSKOYWJBQGKQ-UHFFFAOYSA-N 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- LUSZGTFNYDARNI-UHFFFAOYSA-N Sesamol Natural products OC1=CC=C2OCOC2=C1 LUSZGTFNYDARNI-UHFFFAOYSA-N 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 231100000643 Substance intoxication Toxicity 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 235000010726 Vigna sinensis Nutrition 0.000 description 1
- 244000042314 Vigna unguiculata Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- KYWJAYPVJYSOJC-UHFFFAOYSA-N [N].CCCC Chemical compound [N].CCCC KYWJAYPVJYSOJC-UHFFFAOYSA-N 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000009798 acute exacerbation Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002075 anti-alcohol Effects 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 230000003602 anti-herpes Effects 0.000 description 1
- 230000003199 anti-leptospiral effect Effects 0.000 description 1
- 230000000078 anti-malarial effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229940048961 cholinesterase Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 210000000695 crystalline len Anatomy 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000002478 diastatic effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007159 enucleation Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000010030 glucose lowering effect Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 208000012947 ischemia reperfusion injury Diseases 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 150000004715 keto acids Chemical class 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000008376 long-term health Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000276 neural tube Anatomy 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 208000005346 nocturnal enuresis Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 201000005111 ocular hyperemia Diseases 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 239000008104 plant cellulose Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 description 1
- 229910052683 pyrite Inorganic materials 0.000 description 1
- 239000011028 pyrite Substances 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 230000001869 rapid Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 238000009991 scouring Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229910052717 sulfur Chemical group 0.000 description 1
- 239000011593 sulfur Chemical group 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000007939 sustained release tablet Substances 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 229940102034 valsartan 80 mg Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/36—Vegetable material
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/36—Vegetable material
- A21D2/362—Leguminous plants
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/36—Vegetable material
- A21D2/366—Tubers, roots
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/36—Vegetable material
- A21D2/38—Seed germs; Germinated cereals; Extracts thereof
Abstract
The present invention relates to a kind of functional food and preparation method thereof, be specifically related to cookies of a kind of early prevention and treatment type 2 diabetes mellitus and preparation method thereof.The cookies of a kind of early prevention and treatment type 2 diabetes mellitus, including the raw material of following weight proportioning: Radix Et Rhizoma Fagopyri Tatarici 18 30g, Semen vignae sinensis 30 50g, Semen sojae atricolor 15 20g, roasting fragrant Semen Sesami Nigrum 15 20g, Fructus Tritici aestivi 80g, Rhizoma Polygonati 9 15g, Folium Mori 69 g, Rhizoma Dioscoreae 15 30g, Fructus Momordicae charantiae 15 25 g, Radix Puerariae 6 15g, Rhizoma Polygonati Odorati 6 12g, water are appropriate.Cookies provided by the present invention is pure natural, conventional food materials formula, avirulence, nutritious, edible safety, intervention effective function of polysaccharide food.
Description
Technical field
The present invention relates to a kind of functional food and preparation method thereof, be specifically related to the cake of a kind of early prevention and treatment type 2 diabetes mellitus
Do and preparation method thereof.
Background technology
Diabetes are that the metabolism that development occurs based on defect of insulin secretion and this basic pathology of insulin resistant is combined
Simulator sickness.The progress sent out along with the course of disease, it may appear that the heart, brain, kidney, optical fundus, external perihaemal canal, neural infringement multiple complications, dead
Rate is only second to tumor, cardiovascular and cerebrovascular disease has become the third-largest killer.Current clinical treatment both domestic and external, uses for the most true more
The type 2 diabetes mellitus people examined, awards orally-taken blood sugar reducing medicine or/and insulin is treated.And for existing Type 2 Diabetic morbidity wind
Danger, impaired fasting glucose (IFG), the sub-health population of impaired glucose tolerance, still lack effective product and carry out early prevention intervention.
This part of sub-health population, will soon become by evolving development if can not get early intervention preventing and treating 15% at China's sickness rate
For type 2 diabetes mellitus.Accomplish that " prevention of diseae, disease preapre for an unfavorable turn of events, and have become anti-heavy " actively controls this disease and do not develop, and can be to Healthy People
Fuselage state changes, and is the viewpoint of modern medicine.The traditional Chinese medical science and Western medicine drug blood sugar lowering curative effect phase currently for treating diabetes
To relatively strong, the patient of rising slight to blood glucose uses, and is easily generated hypoglycemia and occurs.And the most not at impaired fasting glucose (IFG), Fructus Vitis viniferae
The impaired glucose tolerance stage formulates therapeutic dose and sets indication.And all drug all also exist some drug side effectes, for a long time
Application rapid wear hepatic and renal function, is easily generated drug resistance.And the most nonnutritive composition, it is impossible to accomplish to provide nutrition for health preserving.Medicine
All without good mouthfeel, use too early, have heavily to control and gently prevent, need the disadvantage that medical expense is higher, it is impossible to enter from people's basic health preserving angle
Row effectively preventing.
Although having some medicated diet to use foodstuff to do dietetic therapy use in the market, but it being simple to there is diet therapy formulation, medical knowledge is explained
Incomplete, ingredient extracting method is imperfect, it is impossible to accomplishes that functional factor organically combines with food, and cooks out good mouthfeel, sends out
The effect that the prevention therapeutic intervention blood glucose waved raises, and lack can the measure of storage life for a long time, eat and carry the most less
Convenient, in place of being the shortcoming and defect that existing medicated diet product exists.
Along with the raising of people's living standard, people are to health preserving pay attention to day by day, to existing Type 2 Diabetic morbidity wind
The patient group of danger, impaired fasting glucose (IFG), impaired glucose tolerance and Newly diagnosed diabetes, develop can health preserving, can prevent and treat again
The functional food of this sub-health population and Newly diagnosed diabetes people is urgent and the most necessary, is one and benefits the nation and the people
Good object of invention, after having the subhealth state people of impaired glucose tolerance to eat, can play and prevent and cure diseases, carry out from source
Intervene and the effect of auxiliary treatment type 2 diabetes mellitus, be of value to this part population healthy, people has been arrived in diseases prevention and the embodiment that gets rid of illness
Carry out among class nature animation, it is to avoid the mouthfeel that medicine need to be used to be brought is pained and bigger the lacking of drug side effect
Point, and for country's Economy type medicine expense, can be to carry out China's chronic disease management and health control for family's Economy type medicine spending
Work in the urgent need to.
Summary of the invention
It is an object of the invention to for the deficiencies in the prior art, it is provided that one can nourishing YIN and clearing away heat, strengthening the spleen and nourishing the stomach,
Promoting the production of body fluid to quench thirst, kidney tonifying righting, the black hair that nourishes blood, slow down aging, the cookies of early prevention and treatment type 2 diabetes mellitus of raising immunity and system thereof
Make method.
The technical scheme is that
The cookies of a kind of early prevention and treatment type 2 diabetes mellitus, including the raw material of following weight proportioning: Radix Et Rhizoma Fagopyri Tatarici 18-30g, Semen vignae sinensis 30-
50g, Semen sojae atricolor 15-20g, Semen Sesami Nigrum 15-20g, Fructus Tritici aestivi 80g, Rhizoma Polygonati 9-15g, Folium Mori 6-9 g, Rhizoma Dioscoreae 15-30g, Fructus Momordicae charantiae
15-25 g, Radix Puerariae 6-15g, Rhizoma Polygonati Odorati 6-12g, water are appropriate.
Concrete, the cookies of a kind of early prevention and treatment type 2 diabetes mellitus includes the raw material of following weight proportioning: Radix Et Rhizoma Fagopyri Tatarici 30g, cowpea
Bean 50g, Semen sojae atricolor 20g, roasting fragrant Semen Sesami Nigrum 20g, Fructus Tritici aestivi 80g, Rhizoma Polygonati 10g, Folium Mori 6g, Rhizoma Dioscoreae 30g, Fructus Momordicae charantiae 25 g, Radix Puerariae
10g, Rhizoma Polygonati Odorati 6, water are appropriate.
The manufacture method of the cookies of a kind of early prevention and treatment type 2 diabetes mellitus, comprises the steps:
(1) Radix Et Rhizoma Fagopyri Tatarici, Semen vignae sinensis, by featured, Semen sojae atricolor is according to aforementioned proportion proportioning, and is respectively washed, is soaked in clear cold boiled water
In water, Radix Et Rhizoma Fagopyri Tatarici immersion 1 hour, Semen vignae sinensis immersion 3 hours, Semen sojae atricolor soak 8 hours;
(2) Rhizoma Polygonati, by selected mistake, Folium Mori, Rhizoma Dioscoreae, Fructus Momordicae charantiae, Radix Puerariae, Rhizoma Polygonati Odorati prepare in proportion, and wrap use with medicated diet bag
Refrigerant boiled water is soaked in porcelain earth pot 50 minutes, the most boiled, and first intense fire water opens rear exchange of notes fire, continues
Within 55 minutes, boil medicine into juice;
(3), boil medicine in step (2) water by firm boiled when, put into Semen sojae atricolor (10 g) and liquid medicine with decocting 20 minutes after, then
After placing into Semen vignae sinensis (25 g) same with liquid medicine pan-fried 15 minutes, it is finally putting into Radix Et Rhizoma Fagopyri Tatarici (15 g) with medicine juice with decocting 20 minutes, stops working
Except medicinal residues, pour out Radix Et Rhizoma Fagopyri Tatarici, Semen vignae sinensis, Semen sojae atricolor and medicine juice that first part of medicine is decocted;
(4), used medicinal residues in step (3) are placed again in porcelain earth pot, carry out again according to the method boiled medicine in step (2)
Secondary boil medicine, be sequentially added into the Semen sojae atricolor with step (3) equivalent, Semen vignae sinensis, Radix Et Rhizoma Fagopyri Tatarici by the method that step (3) is same simultaneously, obtain
Radix Et Rhizoma Fagopyri Tatarici, Semen vignae sinensis, Semen sojae atricolor and the medicine juice that two parts of medicines are decocted, is then combined in one by Radix Et Rhizoma Fagopyri Tatarici, Semen vignae sinensis, Semen sojae atricolor and medicine juice that twice medicine is decocted
Rise;
(5), with wall-breaking machine, Radix Et Rhizoma Fagopyri Tatarici, Semen vignae sinensis, Semen sojae atricolor and the medicine juice that twice medicine is decocted is carried out broken wall treatment 3 minutes, obtain breaking cellular wall
After the food medicine juice mixed serum containing the function of blood sugar reduction factor;
(6), selected Semen Sesami Nigrum is baked out fragrance;
(7) after, the Semen Sesami Nigrum of roasting perfume (or spice) and Fructus Tritici aestivi powder raw material being proportionally mixed and added to the breaking cellular wall that step (5) obtains
In food medicine juice mixed serum containing the function of blood sugar reduction factor, (between each raw material, allocation ratio is Radix Et Rhizoma Fagopyri Tatarici 3 by weight
Part, Semen vignae sinensis 5 parts, black bean powder 2 parts, wheat germ powder 8 parts, roasting fragrant Semen Sesami Nigrum 2 parts), stir and become flour mixed with adulterants agglomerate;
(8) the flour mixed with adulterants agglomerate with function of blood sugar reduction, by step (7) obtained, die mould become fritter cookies and point every part be
10g, dries, vacuum packaging.
Concrete, step (6) to be baked Semen Sesami Nigrum and uses baking box, its operating process is as follows:, Semen Sesami Nigrum is put baking tray and smears
Flat, do not get wet;, it is raised to 150 DEG C etc. furnace temperature and places into baking;, to take chopsticks to turn over every 3~5 minutes when baking and (prevent
Adustion), turn off baking box when 10 minutes, use the remaining temperature of baking box slowly to dry (wanting variable interval to turn over);, Semen Sesami surface is golden yellow
Golden yellow the most permissible.
The cookie formulation that the present invention provides is mainly for the upper eliminating mass " type is hindered in lung-heat Tianjin " of diabetes and middle eliminating mass " gastric heat Tianjin
Lose type, taste weakness of QI type " and lower eliminating mass " early stage of deficiency of kidney-YIN card " Diet Therapy.Type and gastric heat fluid deficiency type are hindered in lung-heat Tianjin, belong to
In intense heat due to deficiency of YIN type diabetes, its disease insulin releasing is normal or higher, and prompting islet function is normal, is more common in diabetes
From the beginning of or the disease of acute exacerbation.The type rule for the treatment of is hindered in lung-heat Tianjin: clearing heat and moistening lung, promoting the production of body fluid to quench thirst, adapted Rhizoma Polygonati Odorati, Folium Mori, Radix Puerariae;Gastric heat
The fluid deficiency type rule for the treatment of: eliminating stomach-fire, YIN supplementing and fluids increasing, adapted Radix Et Rhizoma Fagopyri Tatarici, Fructus Momordicae charantiae.Taste weakness of QI type, the early stage disease of deficiency of kidney-YIN belong to
Type of deficiency of both QI and YIN insulin secretion delayed-type, prompting islets of langerhans reserve function is not enough, is more common in diabetes disease in mid-term.Taste weakness of QI
The type rule for the treatment of: replenishing QI to invigorate the spleen, promoting the production of body fluid to quench thirst, adapted Rhizoma Polygonati, Rhizoma Dioscoreae, Semen vignae sinensis;The early stage rule for the treatment of of kidney-yin deficiency type: YIN nourishing is reinforced the kidney, and joins
With Semen sojae atricolor, Semen Sesami Nigrum.Full nutrition element for diabetes supplements, adapted wheat germ powder.Radix Et Rhizoma Fagopyri Tatarici in formula, Semen vignae sinensis, black
Bean, Fructus Tritici aestivi are paddy wheat food, and Semen Sesami Nigrum is seed group food.They not only can provide abundant nutrient to people: carbon
Outside hydrate, protein, fat, vitamin, mineral, trace element (zinc, chromium, manganese, copper, selenium, magnesium), plant cellulose,
Possibly together with dropping hypoglycemic functional factor.As: the wide intestinal of (1), Radix Et Rhizoma Fagopyri Tatarici appetizing, the therapeutic method to keep the adverse QI flowing downwards is the most long-pending, heat-clearing and toxic substances removing, and dehumidifying is dispeled the wind,
Relieve the effect of alcohol parasite killing, is high flavone crop, and its bioflavonoids is mainly composed of Lu Ding, and Pi Su, Lu Dingneng promote the secretion of insulin,
Contained zinc and selenium can promote insulin synthesis thus reduce blood glucose;(2), Semen vignae sinensis invigorating the spleen and replenishing QI, tonifying kidney and promoting digestion, and the five internal organs, adjust battalion
Defend, spermatogenesis marrow, only quench one's thirst, containing the phospholipid of insulin secretion, zinc and selenium can be promoted, glycometabolic effect can be participated in;(3),
Semen sojae atricolor the kidney invigorating tonifying YIN, invigorating spleen to remove dampness, have invigorate blood circulation, diuretic, effect of dispeling the wind, detoxifying, rich in proteins, aminoacid, and rich in micro-
The nutritional labelings such as secondary element zinc, ferrum, calcium, molybdenum, selenium, copper, phosphorus, have reduction blood glucose, reduce blood viscosity, delaying human body caducity etc.
Important function;(4), Semen Sesami Nigrum energy invigorating the liver and kidney, moistening five ZANG-organs, its extract can increase glycogen in liver and muscle with reducing blood glucose
Content, moreover it is possible to blood fat reducing, prevent arteriosclerosis;(5), Fructus Tritici aestivi is rich in having various nutrients and mineral to be referred to as " people
Class natural nutrition treasure-house ".The protein content of 50g Fructus Tritici aestivi is equivalent to the protein content of 4 eggs.Required containing 8 kinds
Aminoacid.Contained vitamin B1, B2, ferrum, potassium amount considerably beyond flour.In Fructus Tritici aestivi, the content of vitamin E is vegetable oil
Champion, be assigned the name of " long-lived vitamin treasure-house ".There is anticancer, cholesterol reducing, blood sugar lowering, qi-restoratives nourish blood effect.Institute
Have containing zinc element and dietary fiber etc. and reduce cholesterol and effect of prevention diabetes.
In formula, Rhizoma Polygonati, Folium Mori, Rhizoma Dioscoreae, Fructus Momordicae charantiae, Radix Puerariae, Rhizoma Polygonati Odorati are integration of edible and medicinal herbs Chinese medicine, all contain can drop hypoglycemic
Functional factor: (1), Rhizoma Polygonati energy nourishing YIN and moistening the lung, invigorating the spleen and replenishing QI, Zishen fill fine, polygonatum polysaccharide can be by promoting that insulin and C peptide divide
Secrete and reduce blood sugar level.Rhizoma Polygonati methanolic extract has hypoglycemic activity to the mice that blood glucose raises, and can substantially resist on kidney
Blood glucose caused by parathyrine raises;(2), Folium Mori energy wind-dispelling heat-dissipating, clearing away lung-heat and moistening for dryness, the Rat Experimental that alloxan is caused sugar
Urine disease has therapeutical effect;(3), Rhizoma Dioscoreae energy supplementing QI and nourishing YIN, spleen reinforcing lung kidney, Chinese yam polysaccharide have fall hypoglycemic effect, to four oxygen
The diabetes mice that pyrimidine causes has prevention and therapeutical effect, and the blood glucose that significantly can cause antiadrenergic drug and glucose
Raise;Chinese yam polysaccharide can reduce the content of microsome lipid peroxide, has the effect of preferable antioxidation, slow down aging;(4),
Fructus Momordicae charantiae energy clearing away heat and removing summer, removing toxic substances improving eyesight, kidney and spleen invigorating, reduce blood glucose, bitter gourd polypeptide class material, have and quickly reduce blood glucose, regulation
Blood fat, raising immunity function, can prevent and improve the complication of diabetes;(5), Radix Puerariae yang invigorating expelling pathogenic factors from muscles, rash antidiarrheal, relieving restlessness
Quench the thirst, bring down a fever, dredge the meridian passage.Radix Puerariae have hypoglycemic activity, and alloxan hyperglycemia mouse blood sugar can be made to decline, and can be right
Adrenolytic blood glucose increasing effect, and make serum cholesterol content reduce.(6), Rhizoma Polygonati Odorati nourishing YIN and moistening the lung, nourishing the stomach to promote the production of body fluid, have double
To regulation blood glucose effect, make euglycemia raise, reduce experimental hyperglycemia simultaneously;The methanolic extract of Rhizoma Polygonati Odorati is to epinephrine
The blood glucose value of caused hyperglycemia mice has obvious reduction effect, and has the tendency improving resistance to sugar function, one of its mechanism of action
Being to inhibit liver glycolysis system, the rat blood sugar that glucose sugar and alloxan cause is raised by Rhizoma Polygonati Odorati inhibitory action.
In formula, the detailed annotation of each raw material is as follows:
(1), Radix Et Rhizoma Fagopyri Tatarici, its nutritive value shelter has first of cereal crops, and not only rich in nutrition content is of high nutritive value, and
The extraordinary trace element lacked containing other cereal crops and medicinal ingredient, to modern " ciril disease ", and nearly all in old
Year cardiovascular and cerebrovascular disease has prevention and treatment function.
Meridian distribution of property and flavor: cool in nature, sweet in the mouth, enters spleen, stomach, large intestine channel.
Effect: the wide intestinal of appetizing, the therapeutic method to keep the adverse QI flowing downwards is the most long-pending, heat-clearing and toxic substances removing, and dehumidifying is dispeled the wind, and relieve the effect of alcohol parasite killing.For controlling, the intestines and stomach is stagnant, stomachache is let out
Rush down, dry cholera, mouth dysentery, red wandering erysipelas poison, carbuncle carbuncle on the back, soup fire are burnt, scrofula, clavus, hypertension, diabetes, spontaneous perspiration, inclined head
Bitterly, purpura, nebulousurine leucorrhea.
Nutritional labeling and medicinal ingredient: rich in proteins, carbohydrate, water soluble dietary fiber, VifE, nicotinic acid, Lu
The various trace elements such as fourth, oleic acid, linoleic acid and potassium, calcium, magnesium, ferrum, zinc, selenium.
Dietary function: Radix Et Rhizoma Fagopyri Tatarici is high flavone crop,, its bioflavonoids be mainly composed of Lu Ding, Pi Su.Lu Dingneng
Promoting the secretion of insulin, zinc and selenium can promote insulin synthesis thus reduce blood glucose:, flavone can keep the crisp of blood capillary
Property and permeability can be used for prophylaxis of hypertension, diabetes are hemorrhage and patients w ith peptic ulcer disease is hemorrhage, can make blood pressure be remarkably decreased, and slow down the heart
Rate, coronary artery dilator and resisting myocardial ischemia;, oleic acid, linoleic acid can reduce human body blood fat, is also prostatic important set
Become part., magnesium can promote human fiber's protein dissolution, distend the blood vessels, anticoagulant block formation, there is the work of embolism resistance
With, it is also beneficial to reduce serum cholesterol.
Edible compatibility and incompatibility of drugs: preferably: the equal edible of population, be especially suitable for inappetence, diabetics.
Avoiding: because Semen Fagopyri Esculenti is cooler, preferably move cold after food, send out carbunculosis, skin allergy, Deficiency and coldness of spleen and stomach and tumor person should not eat
With.It is unsuitable for that digestive function is weak, cold syndrome of the stomach, allergy, often diarrhoea person.
(2), Semen vignae sinensis meridian distribution of property and flavor: property is put down, sweet-salty.Enter spleen, kidney channel.
Effect: invigorating the spleen and replenishing QI, strengthening the spleen and nourishing the stomach, and the five internal organs, adjust battalion to defend, and spermatogenesis marrow is only quenched one's thirst, and digestion promoting, the kidney invigorating increase appetite.
Improve immunity, frequent micturition, seminal emission and some gynecological's class diseases are had auxiliary curative effect.
Nutritional labeling and medicinal ingredient: containing fat, protein, carbohydrate, calcium, zinc, ferrum, phosphorus, carotene,
VitB1, VitB2, VitC and nicotinic acid, the composition such as dietary fiber, wherein the content of phosphorus is the highest.
Dietary function:, Semen vignae sinensis contain the phospholipid that can promote insulin secretion, glycometabolic effect can be participated in.It is sugar
The ideal chose of urine patient;, protein containing high-quality, the mineral such as a certain amount of saccharide, vitamin and calcium, phosphorus, ferrum
Metabolism with trace element-selenium and zinc, beneficially human body;, body can be made to keep normal digestion containing vitamin B group
Glandular secretion and the function of gastrointestinal motility, balance cholinesterase activity, is conducive to digestion, orectic effect;, contain
VitC can promote the synthesis of antibody, suppression virus, improves the immunocompetence of body;, have strengthening spleen, tonifying kidney effect, to frequent micturition, something lost
Essence and some gynecological's functional diseases have auxiliary therapeutic action.
Edible compatibility and incompatibility of drugs: preferably: diabetes patient, weakness of the spleen and stomach, dyspepsia, dyspeptic abdominal distention, thirsty polyuria, women's leukorrhagia, kidney
Void, functional weak, vitamin B1 deficiency, uremia and old people suitably eat.(boil flavouring, dyspepsia person the most preferably eats again
With, and food therapy effect is notable).Avoid: it is stagnant that property at most eaten by Semen vignae sinensis.Polyphagia, the people of the stagnation of QI, just knot avoid clothes.
(3), Semen sojae atricolor meridian distribution of property and flavor: property is put down, sweet in the mouth.GUIXIN, kidney channel.
Effect: the kidney invigorating tonifying YIN, invigorating spleen to remove dampness, heat extraction detoxifies.For: yin deficiency of suffering from a deficiency of the kidney, polydipsia of quenching one's thirst, frequent micturition;Liver and kidney
The deficiency of YIN, have a dizzy spell, poor vision or early whitening of beard and hair;Tinea pedis edema or arthralgia chiefly caused by damp pathogen contracture;Lumbago;In abdomen, contraction is anxious has a pain or dysentery abdomen
Carbuncle;Take the medicine of a warm nature uncomfortable.
Nutritional labeling and medicinal ingredient: rich in proteins, aminoacid, vitamin B, folic acid, nicotinic acid, pantothenic acid, crude fibre, ore deposit
Material, have invigorate blood circulation, diuretic, effect of dispeling the wind, detoxifying;Rich in nutritional labelings such as trace element zinc, ferrum, calcium, molybdenum, selenium, copper, phosphorus,
There is reduction blood glucose, reduce the important function such as blood viscosity, delaying human body caducity.
Dietary function:, can pre-preventing obesity, reduce cholesterol, reduce suffer from diabetes risk., to various edema, body
Void, apoplexy, suffer from a deficiency of the kidney, infantile night sweat, spontaneous perspiration, perspire after calentura, children's's enuresis nocturna, lumbago during pregnancy, soreness of the waist and knees, old kidney
Empty deaf, the diseases such as leucorrhea is a lot of, postpartum apoplexy, quadriplegia have significant curative effect;, all alimentary toxicosis or drug intoxication, all
Available decoction of black soybean and Radix Glycyrrhizae decoct soup drink, with removing toxic substances;
Edible compatibility and incompatibility of drugs: preferably: various edema, body is empty, and apoplexy is suffered from a deficiency of the kidney, diabetes, alopecia patients.Avoid: children's is difficult to many
Food;After Semen sojae atricolor fries, hot many trenchermans easily get angry greatly, unsuitable polyphagia;Semen sojae atricolor avoids five ginsengs, Radix Gentianae;Semen sojae atricolor avoid with deer pockmarks,
Cortex Magnoliae Officinalis is with food.
(4), Semen Sesami Nigrum
Meridian distribution of property and flavor: property is put down, sweet in the mouth, nontoxic.Enter liver, kidney, lung, spleen, large intestine channel.
Effect: nourishing the liver and kidney, loosening bowel to relieve constipation, health preserving black hair, moistening five ZANG-organs, lactogenesis, keep fit, anti-ageing effect of waiting for a long time.For liver
Blurring of vision caused by kidney deficiency, waist soreness, Hiccough and deaf, the disease such as dizziness, early whitening of beard and hair, post disease alopecia, dryness of the intestine constipation is treated
Effect is notable.
Nutritional labeling and medicinal ingredient: every 100g 17g in protein, fat 48g, dietary fiber 19g potassium 291mg, calcium
814mg, magnesium 223mg, ferrum 26mg.Additionally, it is also rich in the necessary 8 kinds of amino of zinc, copper, manganese, cobalt, selenium, vitamin E and human body
The nutritional labelings such as acid, oleic acid, linoleic acid.Possibly together with sesamin, arachidic acid, sesamol, oleic acid, palm fibre keto acid, sterol, lecithin,
Vitamin A, vitamin B, vitamin D etc..Contained lecithin, can prevent alopecia and bleach too early, black hair is beautiful.
Consumption: decoct soup, 9-16g..
Dietary function:, invigorating the liver and kidney, moistening five ZANG-organs;, modern medicine study confirm, Semen Sesami Nigrum can reduce blood glucose (extract
Rat blood sugar can be lowered, increase glycogen content in liver and muscle, but heavy dose can reduce glycogen content on the contrary;Semen Sesami Nigrum contains
Sugar amount only 4.3%), moreover it is possible to blood fat reducing, prevent arteriosclerosis., VitE, the crystalline lens of eyes is had good impact, has antioxygen
Change and remove the effect of free radical;, lignol's compound, there is the effect of antioxidation, anti-tumor activity, moreover it is possible to bite after enhancing
The cytophagous ability of cell;
Edible compatibility and incompatibility of drugs: preferably: early whitening of beard and hair, dried and withered hairs are dealt with, waist soreness person, middle-aged and elderly people, physical weakness, hyperlipemia, high blood
The patients such as pressure, anemia, senile asthma, pulmonary tuberculosis, urticaria, corpora haemorrhagicum void, constipation preferably eat.Avoid: suffer from chronic enteritis, loose stool
Condition subject's inedibilities such as diarrhoea, impotence of man, seminal emission.
(5), Fructus Tritici aestivi effect: Fructus Tritici aestivi is that Semen Tritici aestivi Middle nutrition is worth the highest part, because of containing several mineral materials
And it is referred to as " mankind's natural nutrition treasure-house ".There is anticancer, cholesterol reducing, blood sugar lowering, qi-restoratives nourish blood effect.For supplementing albumen
Matter, vitamin E, B1, B2, trace elements iron, potassium, zinc, anticancer, blood fat reducing, blood sugar lowering, lose weight, take care of hair, the crowd such as speckle dispelling.Nutrition becomes
Point: containing protein, several amino acids, vitamin B1, vitamin B2, dietary fiber, ferrum, potassium, zinc and sulfur-bearing polyphenoils one
The nutritional labelings such as one glutathion.
Dietary function: Fructus Tritici aestivi has the effects such as anticancer, reduction cholesterol, blood sugar lowering, qi-restoratives nourish blood., contained by it
The sweet peptide of Guang can generate oxidase in the presence of selenium element, internal chemical carcinogen can be made to lose toxicity, and can protect brain,
Promote infants growth and development;, contained zinc element and dietary fiber etc. have and reduce cholesterol and effect of prevention diabetes;、
Fructus Tritici aestivi also plays facilitation to the growth of intestinal beneficial flora;, Fructus Tritici aestivi be also used for fat-reducing, speckle dispelling, massage,
Hair care etc..
Edible compatibility and incompatibility of drugs: preferably: common people can eat, and is the health-care good product of child, old people, brain worker.Semen Tritici aestivi
Plumule is nutritious, all without being avoided.
(6), Rhizoma Polygonati meridian distribution of property and flavor: property is put down, sweet in the mouth.Enter spleen, lung, kidney channel.
Effect: nourishing YIN and moistening the lung, invigorating the spleen and replenishing QI, Zishen fill fine.For weakness of the spleen and stomach, fatigue and asthenia deficiency of kidney yin, xerostomia food
Less, deficiency of the lung cough caused by dryness, asthenia of essence and blood, soreness of the waist and knees, early whitening of beard and hair, interior-heat quench one's thirst, pulmonary tuberculosis hemoptysis, after being ill body void lack of appetite, muscles and bones soft
The diseases such as weak, rheumatism.
Nutritional labeling and medicinal ingredient: every 100g, containing protein 8.4g, starch 20g, reducing sugar 5g, additionally contains multiple
The compositions such as aminoacid (8 kinds of aminoacid such as lysine), vitamin, essence polysaccharide (A, B, C) polygonatum rhizome oligosaccharide (A, B, C), nicotinic acid, west
Elder brother's class, lymphatic temperament, solid soap are sweet.
Dietary function:, (polygonatum polysaccharide can reduce blood sugar level by promoting insulin and C peptide to secrete to blood sugar lowering.
Rhizoma Polygonati methanolic extract has hypoglycemic activity to the mice that blood glucose raises, and can be substantially to the blood glucose liter caused by antiadrenergic drug
High);, invigorating the spleen and replenishing QI, strengthening by means of tonics, profit cardiopulmonary, muscle reinforcing and bone strengthening;, rheumatalgia, the rapids disease of wind;, treatment coronary heart disease,
Hypotension, leukopenia;, regulation immunity, (polygonatum polysaccharide has suppression to H22 solid tumor, SI80 ascites tumor to antitumor
Effect), antibacterial, antiinflammatory, the antiviral effect of anti-herpes simplex virus (polygonatum polysaccharide have);, resisting fatigue, slow down aging (can subtract
The generation of few tissue oxygen free radical), can improve learning memory,, adjust fat (polygonatum polysaccharide can suppress cholesterol biology to close
Become, the atherosis immersional wetting with fatty liver of arteries can be prevented and treated);, have and reinvent lug structure and function.
Edible compatibility and incompatibility of drugs: preferably: Rhizoma Polygonati is the comparatively ideal product taken a tonic or nourishing food to build up one's health of middle-aged and elderly people, because middle-aged and elderly people not only yang-energy is more weak, and
And cloudy liquid has deficiency more, the flat gentleness of its property of Rhizoma Polygonati, effect slowly, for a long time clothes can enriching spleen-QI and spleen cloudy, the lung moistening and production of body fluid promoting, kidney tonifying mends essence,
Having blood pressure lowering, blood sugar lowering, an increase coronary flow, blood fat reducing, (and the product of all big benefit warm-dryness syndrome may band to delay arteriosclerosis effect
Reduce blood fat and delay the effects such as arteriosclerosis).Avoid: invasion by pathogenic cold is had loose bowels, phlegm-damp painful abdominal mass medicine, stagnation of QI person avoid clothes.
(7), Folium Mori meridian distribution of property and flavor: cold in nature, sweet-bitter flavor.Return lung meridian, Liver Channel.
Effect: wind-dispelling heat-dissipating, clearing away lung-heat and moistening for dryness, liver heat removing and eyesight improving.For anemopyretic cold, lung-heat type cough, headache and dizzy, conjunctival congestion dusk
Flower, migratory arthralgia, herpes, lower limb skin are swollen.
Nutritional labeling and medicinal ingredient: Folium Mori contain rutin, Pericarpium Citri tangerinae hesperidin plain, different, Pericarpium Citri tangerinae element one 3 one three glucosides, trace
A sitosterol and Oleum Camelliae sterol, a sitosterol, a D glucoside alcohol etc..The volatile oil component of Folium Mori has acetic acid, propanoic acid, fourth
Acid, isopropylformic acid., valeric acid, isovaleric acid, acetic acid, different acetic acid, methyl salicylate, sucrose, fructose, glucose, Radix Asparagi aminoacid and
The aminoacid such as glutamic acid.
Dietary function:, have antipyretic eliminate the phlegm, analgesic activity.Light heating that affection due to external wind and heat is caused, cough, eye red as
Flu }, have therapeutical effect;, experimental diabetes in rats that alloxan caused have therapeutical effect;, reduce blood pressure
And diuresis;, the water decoction of high concentration have anti-leptospiral effect in vitro;, have the effect of beauty treatment, control Cuo
Skin ulcer, brown macules of dispelling.
Edible compatibility and incompatibility of drugs: preferably: anemopyretic cold, hot conjunctival congestion and swelling pain, blood deficiency dizziness person uses.Avoid: nothing.
(8), Rhizoma Dioscoreae meridian distribution of property and flavor: property is put down, sweet in the mouth.Enter spleen, lung, kidney channel.
Effect: supplementing QI and nourishing YIN, spleen reinforcing lung kidney.For weakness of the spleen and stomach, the deficiency of the lung, deficiency of both the lung and kidney, nephritis, antidiarrheal dysentery, the liquid that reduces phlegm,
Support skin, blood sugar lowering, defying age;Rhizoma Dioscoreae has special health-care effect to human body, can prevent the fat flowing of cardiovascular system,
Prevent arteriosclerosis from occurring to early, reduce subcutaneous fat flowing, it is to avoid obesity occurs.
Nutritional labeling and medicinal ingredient: containing several amino acids and glycoprotein, lymphatic temperament, carotene, VifC, VitB, dimension
Raw element B2, nicotinic acid, choline, amylase, polyphenol oxidase etc.., Chinese yam polysaccharide, phospholipid composition there is good immunity work
With;Chinese yam polysaccharide has the hypoglycemic effect of fall, and the diabetes mice causing alloxan has prevention and therapeutical effect, and
The blood glucose that significantly can cause antiadrenergic drug and glucose raises;, Chinese yam polysaccharide can reduce microsome lipid peroxide
Content, have the effect of preferable antioxidation, slow down aging;, have the effect of antitumor, mutation;, Rhizoma Dioscoreae can suppress
Gastric emptying and intestinal impetus, alleviate enterospasm and resist unstrung effect, can alleviate the absorption function of small intestinal, suppresses serum
Diastatic secretion;, Rhizoma Dioscoreae is in prevention and alleviates Ischemia-reperfusion Injury and promotes there is significantly work in terms of kidney Regeneration and Repair
With;, Rhizoma Dioscoreae have a kind of protein, have the effect regulating internal acid-base balance;, blood urea nitrogen have irritation, analgesia,
The effect that antiinflammatory is antibacterial, also has the effect repairing epithelial tissue simultaneously.
Dietary function: control insufficiency of the spleen lack of appetite, incessant chronic diarrhea, the deficiency of the lung breathes heavily expectorant, emission due to deficiency of the kidney, leukorrhagia, frequent micturition, and deficiency-heat is quenched one's thirst, and (Rhizoma Dioscoreae is many
Sugar reduces blood glucose) etc..
Diet compatibility and incompatibility of drugs: preferably: syndrome of spleen-deficiency, deficiency of the lung disease, nephrasthenia syndrome, deficiency of both QI and YIN disease of quenching one's thirst;All bodies are empty, empty after being ill win, sugar
Urinate medical history sick, chronic and bed-wetting person eats;Use is preferably given birth in nourishing YIN, and invigorating the spleen to arrest diarrhea, suitable parching to brown are used;Avoid: wet Sheng fullness in the epigastrium and abdomen or have wet
Heresy, stagnant person avoids clothes;Constipation due to dry stool person's diet, avoids and together eats in alkalescent medicine, suffers from diarrhoea, catches a cold, heating person should not take, and avoids
Carassius auratus, Radix Kansui.
(9), Fructus Momordicae charantiae: meridian distribution of property and flavor: cold in nature, bitter in the mouth.Enter stomach, the heart, Liver Channel.
Effect: clearing away heat and removing summer, removing toxic substances improving eyesight, reduce blood glucose, kidney and spleen invigorating, QI invigorating tonifying YANG, improve immunity of organisms, have anti-
Cancer, the effect of antiviral.For heatstroke, summer-heat excessive thirst, conjunctival congestion and swelling pain, carbuncle erysipelas, burn and scald, the people of oliguria eat.
Nutritional labeling and medicinal ingredient: fruit contains Fructus Momordicae charantiae glucoside, is cupreol-β-D-glucoside and 5,25-bean steroid
The equimolecular mixture of dienol-3-glucoside.The VitC comparision contents of Fructus Momordicae charantiae enriches, and every hectogram is up to 84 mg, the most still
There are protein, fat, saccharide, calcium, phosphorus and carotene, the nutritional labeling such as VitB.
Dietary function:, bitter gourd polypeptide class material, have quickly reduce blood glucose, regulation blood fat, improve immunity function, energy
Prevent and improve the complication of diabetes;, source containing antimalarial quinine, namely bitterness, can suppress to be overexcited
Heat center, antipyretic and antidote functions can be played;, containing more lipoprotein, can promote that human immune system resists cancer
Cell, can strengthen human body and exempt from function;, containing organic base, the taste nerve of people can be stimulated, make people's appetite stimulator, accelerate gastrointestinal
Move, contribute to digestion;, in summer, child often goes out miliaria, with Fructus Momordicae charantiae scouring to boil water, has heat clearing away, antipruritic, effect of miliaria of dispelling.
Diet compatibility and incompatibility of drugs: preferably: diabetes, acute dysentery, hysteria patient, calentura excessive thirst, taking fluids profusely heatstroke, acute conjunctivitis pain, carbuncle
Erysipelas, malignant boil crowd eat.Avoid;Deficiency and coldness of spleen and stomach, diarrhoea loose stool, the vexed distension of painful abdominal mass, greasy fur on tongue and are avoided use, contraindication in pregnancy.
(10), Radix Puerariae meridian distribution of property and flavor: property is pungent, cool, sweet in the mouth.It is included into spleen, stomach warp.
Effect: yang invigorating expelling pathogenic factors from muscles, rash antidiarrheal, relieving restlessness are quenched the thirst, and bring down a fever, dredge the meridian passage, alcoholic intoxication.
For fever caused by exogenous pathogens have a headache, stiff nape and back carbuncle, quench one's thirst, thirsty, measles is not moved back, hematodiarrhoea, have loose bowels, dizzy
Dizzy headache, apoplectic hemiplegia, obstruction of qi in the chest and cardialgia, ethanol damaging the spleen and stomach.
Nutritional labeling and medicinal ingredient: containing multiple flavone constituents, main active is Dai, daiazi, Pueraria lobota
Root element, puerarin-7-xyloside etc..
Dietary function:, Radix Puerariae normal and hypertension animal are all had certain hypotensive effect, total pyrite and puerarin are bright
Aobvious expansion coronary vasodilator, can make the normal and coronary artery expansion of spasm., Radix Puerariae have hypoglycemic activity, four oxygen can be made phonetic
Pyridine hyperglycemia mouse blood sugar declines, and to adrenolytic blood glucose increasing effect, and serum cholesterol content can be made to reduce., antioxidation, the different flavin of Radix Puerariae substantially suppress Mouse Liver, nephridial tissue and blood, the liter of the lipid peroxide propylene glycol of cerebral tissue
Height, has pole remarkable effect to improving superoxide dismutase activity in blood, cerebral tissue., antitumor, Radix Puerariae extract can activate
The immune systems such as internal macrophage, have certain inhibitory action to multiple cancerous cell such as pulmonary carcinoma., that puerarin can reduce blood is little
The surface activity of plate, the coagulation of suppression epinephrine induced platelet., hepatic injury and high lipid hepatopathy have necessarily by isoflavone
Protective effect., Radix Puerariae have a reduction intraocular pressure effect, and can improve chronic intraocular hypertension, optic nerve axoplasmic flow and optic disc is micro-follows
Ring., regulation immunization, Radix Puerariae can make the foreign body phagocytic function of macrophage M4 activate, and makes under initial infection state
Foreign body is got rid of function and is strengthened, and by the M4 of activation, cellular immunization is imposed impact simultaneously.
Diet compatibility and incompatibility of drugs: preferably:, for exterior syndrome heating, stiff nape and back pain, measles without adequate eruption, calentura is thirsty,
The deficiency of YIN is quenched one's thirst, diarrhea of heat type hematodiarrhoea, diarrhea due to hypofunction of the spleen, blood sugar lowering, blood fat reducing, anti-hypoxia, blood pressure lowering, anti-
Cancer, antipyretic, protect the liver, arrhythmia, the anti-heart strand pain, improve cerebral circulation, improve learning memory,
The patients such as antiplatelet aggregation, anti-alcohol damage;, expelling pathogenic factors from muscles for reducing heat, thoroughly examine and preferably give birth to use, rise
Sun antidiarrheal person preferably simmers use.Avoid:, it is cool in nature, it is easy to dynamic vomitting, cold syndrome of the stomach person is when be cautious use of;, can not
Polyphagia, probably damages gastric qi;, exterior deficiency hyperhidrosis in summer avoids especially.
(11), Rhizoma Polygonati Odorati meridian distribution of property and flavor: cold nature, sweet in the mouth.Enter lung, stomach warp.
Effect: nourishing YIN and moistening the lung, nourishing the stomach to promote the production of body fluid, relieving restlessness are quenched the thirst.Disappear for lung stomach impairment of YIN, cough caused by dryness-heat, dry throat and mouth, interior-heat
Yearningly, deficient fever, rapid digestion of food easily hungry, frequent micturition.
Nutritional labeling and medicinal ingredient: containing fragrant solomonseal rhizome polyoses the first and second the third fourth, Rhizoma Polygonati Odorati mucopolysaccharide, 4-oxo-1,4-pyran-2,6-dicarboxylic acid,
Ring nitrogen butane 1 hydroxy acid, kaempferide galactoside etc..
Dietary function:, have the multiple increased activity removing energy to free radical that can improve body superoxide dismutase
Power, slow down aging;, have two-ways regulation blood glucose effect, make euglycemia raise, reduce experimental hyperglycemia simultaneously;Rhizoma Polygonati Odorati
Methanolic extract has obvious reduction effect to the blood glucose value of the hyperglycemia mice caused by epinephrine, and has improvement resistance to sugar function
Tendency, one of its mechanism of action is to inhibit liver glycolysis system, the rat serum that glucose sugar and alloxan are caused by Rhizoma Polygonati Odorati
Sugar raises inhibitory action;, have the effect of heart tonifying;, blood fat reducing and alleviate structural lesions;, Rhizoma Polygonati Odorati extract has significantly
Antitumor action, the Proliferation Ability of T lymphocyte is showed;, Rhizoma Polygonati Odorati extract immunological liver can be protected to damage, can be to huge
The TNF mono-that phagocyte produces has significant inhibitory action,, for weakling can as typically nourishing use, but effect weak and
Slow, belong to clear benefit, for coronary heart diseases and angina pectoris, join Radix Codonopsis and make ginseng bamboo extractum, it is adaptable to the patient of type of deficiency of both QI and YIN.
Diet compatibility and incompatibility of drugs: stagnation of QI due to phlegm-damp person avoids clothes, the insufficiency of the spleen careful clothes of loose stool person.Stomach has phlegm-damp, and person avoids clothes, and Fructus Jujubae enters soup must
Enucleation, otherwise easily gets angry after food.
Cookies provided by the present invention is pure natural, conventional food materials formula, avirulence, nutritious, edible safety, intervention
Effective function of blood sugar reduction food.The mouthfeel bitterness sense brought because of drug administration can be greatly reduced as daily edible
And drug side effect.Products material wide material sources, food materials formula, process environmental protection, pollution-free, cost of manufacture is low, has health preserving and adjusts
Reason gets rid of illness, nutritious, nice good-looking, well hold properly put, long shelf-life, instant, easily absorb, safely and effectively, thing U.S. valency
Honest and clean advantage.The present invention can carry out prevention from source and intervene diabetes, useful people's health, controls onset diabetes
Rate, and for country's Economy type medicine expense, can be to carry out China's chronic disease management and health control for family's Economy type medicine spending
The good invention product of work.
Detailed description of the invention
Detailed description of the invention 1
The cookies of a kind of early prevention and treatment type 2 diabetes mellitus includes the raw material of following weight proportioning: Radix Et Rhizoma Fagopyri Tatarici 30g, Semen vignae sinensis 50g, Semen sojae atricolor
20g, roasting fragrant Semen Sesami Nigrum 20g, Fructus Tritici aestivi 80g, Rhizoma Polygonati 10g, Folium Mori 6g, Rhizoma Dioscoreae 30g, Fructus Momordicae charantiae 25 g, Radix Puerariae 10g, Rhizoma Polygonati Odorati 6,
Water is appropriate.
The manufacture method of the cookies of a kind of early prevention and treatment type 2 diabetes mellitus, comprises the steps:
(1) Radix Et Rhizoma Fagopyri Tatarici, Semen vignae sinensis, by featured, Semen sojae atricolor is according to aforementioned proportion proportioning, and is respectively washed, is soaked in clear cold boiled water
In water, Radix Et Rhizoma Fagopyri Tatarici immersion 1 hour, Semen vignae sinensis immersion 3 hours, Semen sojae atricolor soak 8 hours;
(2) Rhizoma Polygonati, by selected mistake, Folium Mori, Rhizoma Dioscoreae, Fructus Momordicae charantiae, Radix Puerariae, Rhizoma Polygonati Odorati prepare in proportion, and wrap use with medicated diet bag
Refrigerant boiled water is soaked in porcelain earth pot 50 minutes, the most boiled, and first intense fire water opens rear exchange of notes fire, continues
Within 55 minutes, boil medicine into juice;
(3), boil medicine in step (2) water by firm boiled when, put into Semen sojae atricolor (10g) and liquid medicine with decocting 20 minutes after, then
After placing into Semen vignae sinensis (25 g) same with liquid medicine pan-fried 15 minutes, it is finally putting into Radix Et Rhizoma Fagopyri Tatarici (15 g) with medicine juice with decocting 20 minutes, stops working
Except medicinal residues, pour out Radix Et Rhizoma Fagopyri Tatarici, Semen vignae sinensis, Semen sojae atricolor and medicine juice that first part of medicine is decocted;
(4), used medicinal residues in step (3) are placed again in porcelain earth pot, carry out again according to the method boiled medicine in step (2)
Secondary boil medicine, be sequentially added into the Semen sojae atricolor with step (3) equivalent, Semen vignae sinensis, Radix Et Rhizoma Fagopyri Tatarici by the method that step (3) is same simultaneously, obtain
Radix Et Rhizoma Fagopyri Tatarici, Semen vignae sinensis, Semen sojae atricolor and the medicine juice that two parts of medicines are decocted, is then combined in one by Radix Et Rhizoma Fagopyri Tatarici, Semen vignae sinensis, Semen sojae atricolor and medicine juice that twice medicine is decocted
Rise;
(5), with wall-breaking machine, Radix Et Rhizoma Fagopyri Tatarici, Semen vignae sinensis, Semen sojae atricolor and the medicine juice that twice medicine is decocted is carried out broken wall treatment 3 minutes, obtain breaking cellular wall
After the food medicine juice mixed serum containing the function of blood sugar reduction factor;
(6), selected Semen Sesami Nigrum being baked out fragrance, bake Semen Sesami Nigrum and use baking box, its operating process is as follows:, by Fructificatio Amaurodermatis Rudae
It is floating that fiber crops put baking tray, does not get wet;, it is raised to 150 DEG C etc. furnace temperature and places into baking;, when baking, to take chopsticks every 3~5 minutes
Turn over and (prevent adustion), when 10 minutes, turn off baking box, use the remaining temperature of baking box slowly to dry water (wanting variable interval to turn over);
, Semen Sesami surface is golden yellow the most permissible;
(7) after, the Semen Sesami Nigrum of roasting perfume (or spice) and Fructus Tritici aestivi powder raw material being proportionally mixed and added to the breaking cellular wall that step (5) obtains
In medicine juice mixed serum containing the function of blood sugar reduction factor, (between each raw material, allocation ratio is 3 parts of Semen Fagopyri Esculenti, Semen vignae sinensis 5 by weight
Part, black bean powder 2 parts, wheat germ powder 8 parts, roasting fragrant Semen Sesami Nigrum 2 parts), stir and become flour mixed with adulterants agglomerate;
(8) the flour mixed with adulterants agglomerate with function of blood sugar reduction, by step (7) obtained, die mould become fritter cookies and point every part be
10g, dries, vacuum packaging.
The cookies using the early prevention and treatment type 2 diabetes mellitus that this formula produces carries out actual clinical observation:
Observation crowd: screening has the crowd that blood glucose raises, fluctuates fasting glucose 6.3~7.3mmol/L, the age 24~70
The crowd in year organizes the object of observation as entering, and uses randomized grouping method, is divided into: dietetic therapy group 100 people, matched group 100 people.
Observational technique:
1, the observation crowd meeting inclusion criteria is carried out randomized grouping method, be divided into: dietetic therapy group
100 people, matched group 100 people;
2、, dietetic therapy observe before respectively each example to dietetic therapy group and matched group be selected in observer and carry out
Set up individual and observe table;
, dietetic therapy observe 1 course for the treatment of (28 days) in, the observed people of every example of two groups, all at observed the 1st day, the 14th
My god, the 28th day, monitor each 1 time of 2 hours blood glucoses after fasting glucose, lunch respectively, and record on observation table;
, observe the 1st day, the empty stomach glycolated hemoglobin monitoring two groups of observed people of every example respectively on the 28th day, and record
Observing on table;
3、, by every for dietetic therapy group observed people of example, award the formula cookies that the present invention provides every day, 50g/ time,
2 times/day, edible, 28 days/1 course for the treatment of.Simultaneously by staple food the most original for dietetic therapy group
Amount reduces 100 grams, keeps constant with original staple food total amount every day;
, matched group the most still remain unchanged by original life style and former therapeutic scheme, 28
It is 1 observation stage;
4、, by dietetic therapy group and matched group, the 1st day monitored respectively, the 14th day, the 28th day,
2 hours blood glucose data values and the 1st day after fasting glucose, lunch, monitor on the 28th day
Glycolated hemoglobin data value on an empty stomach, carries out tabulating method check analysis, observes two groups of crowd's foods
Intervention blood glucose food therapy effect before and after treatment,
, sum up tabulating method check analysis result,
Result:
The cookies that the present invention the provides intervention observation of curative effect table to blood glucose (mmol/L)
[ check analysis ]:
, Passing Criteria: fasting glucose normal value: 3.8-6.1 mmol/L, 2h-plasma glucose < 7.8 mmol/L.
, the fasting glucose of dietetic therapy group (dietetic therapy) and 2h-plasma glucose compliance rate value be 100%, hence it is evident that be higher than
The 0% of matched group;
, the fasting glucose of matched group (non-dietetic therapy) and 2h-plasma glucose compliance rate value be 0 %.It is significantly lower than
Dietetic therapy group 100%;
, [history China people blood sugar lowering vegetables grain] cookies dietetic therapy Observation on Intervention that blood glucose is raised of this experiment, to fasting blood
Sugar, the control compliance rate of 2h-plasma glucose have obvious clinical meaning.
The cookies that the present invention the provides intervention observation of curative effect table to glycolated hemoglobin
[ check analysis ]:
, Passing Criteria: glycolated hemoglobin normal value: 7 %.
, the glycolated hemoglobin compliance rate value of dietetic therapy group (dietetic therapy) be 100%, hence it is evident that higher than matched group (non-dietetic therapy)
Value up to standard is 0 %.
, the glycolated hemoglobin compliance rate value of matched group (non-dietetic therapy) be 0 %.Significantly lower than dietetic therapy group 100%;
, [history China people blood sugar lowering vegetables grain] cookies dietetic therapy Observation on Intervention that blood glucose is raised of this experiment, to glycolated hemoglobin
Control compliance rate have obvious clinical meaning.
Conclusion:
By age 24~70 years old, fasting glucose fluctuation 6.3~7.3mmol/L crowd as enter to organize sight check as.Use with
The machine method of dividision into groups, is divided into dietetic therapy group 100 people, matched group 100 people.Dietetic therapy group uses [history China people blood sugar lowering vegetables grain] cookies for each person every day,
50g/ time, 2 times/day, edible, 28 days/1 course for the treatment of.Staple food amount the most original for dietetic therapy group is reduced 100 grams simultaneously, keep
Constant with original staple food total amount every day;Matched group is the most still maintained not by original life style and former therapeutic scheme
Become, within 28 days, be 1 observation stage.Two groups after 28 days, compares the 1st day of dietetic therapy, the 14th day, the 28th day fasting glucose, after the meal
2h blood glucose and glycolated hemoglobin data value compliance rate, carry out tabulating method check analysis, it was therefore concluded that: the fasting blood of dietetic therapy group
It is all 100% that sugar, 2h-plasma glucose and glycolated hemoglobin recover the compliance rate of normal value;The fasting glucose of matched group, after the meal 2h
It is all 0% that blood glucose and glycolated hemoglobin recover the compliance rate of normal value;It is the most useful that this experiment has shown that this product has
Reduce blood glucose food therapy function, can effectively early prevention and intervene type 2 diabetes mellitus pathogenic process.There is the most clinical meaning
Justice.
Model case
Guo, female, 56 years old, retired employees.On October 15th, 2015 is stated at certain hospital admission: found before half a year that oneself is frequent
Discontinuity xerostomia, weak.Medical history has hypertension 6 years, does financial affair 30 years, more with mental activity at ordinary times, muscular labor
Dynamic less.Inspection blood glucose raises, fasting glucose 8.2mmol/L, after the meal 2 hours blood glucose 12.3 mmol/L.Measuring blood pressure, BP143/
96 mmHg.Patient diagnosis: type 2 diabetes mellitus, hypertension.Remedy measures:, blood pressure lowering use Nifedipine sustained release tablets
10mg/ time, 1 times/day, oral;, blood sugar lowering use formula cookies provided in the present embodiment carry out Diet Therapy,
50g every time, every day 2 times, edible (patient reduces 100g every day on the basis of normal diet staple food amount, does not use any blood sugar lowering
Medicine).When the most edible 20 days, check fasting glucose 7.3mmol/L of patient, 2 hours blood glucose 10.5 mmol/ after the meal
L, uses this Formula Diets to treat the most continuously 20 days, fasting glucose 6.2 mmol/L of patient, 2 hours blood glucose after the meal
8.1mmol/L, after be continuing with the dietetic therapy of this formula 20 days, fasting glucose 5.8mmol/L of patient, after the meal 2 hours blood glucose
7.8mmol/L, at this moment the discontinuity xerostomia of patient, weak symptom are completely eliminated, measuring blood pressure, BP130/85 mmHg.Through 60
It dietetic therapy hypoglycemic effect is preferable, and patient is the most satisfied, in the case of not taking medicine and having an injection, that glycemic control is up to standard.
After patient blood glucose is stably normal, in accordance with above Dietotherapy method, health is the most healthy, and glucostasis is normal.
Detailed description of the invention 2
The cookies of a kind of early prevention and treatment type 2 diabetes mellitus unlike detailed description of the invention 1 includes the raw material of following weight proportioning:
Radix Et Rhizoma Fagopyri Tatarici 18g, Semen vignae sinensis 30g, Semen sojae atricolor 15g, roasting fragrant Semen Sesami Nigrum 15g, Fructus Tritici aestivi 80g, Rhizoma Polygonati 9g, Folium Mori 7g, Rhizoma Dioscoreae 15g, hardship
Melon 15 g, Radix Puerariae 6g, Rhizoma Polygonati Odorati 8, water are appropriate.Its manufacture method is with detailed description of the invention 1.
The model case of the formula cookies that edible this detailed description of the invention 2 is provided has as follows:
History, female, 61 years old, retired employees.On January 11st, 2016, at certain hospital admission, is stated: before 2 years, often feel weak and
Blurred vision, does not payes attention to, the most medical treatment.When Physical Examination, discovery fasting glucose 7.3mmol/L, 2 hours after the meal
Blood 11.6mmol/L.Teaching 28 years, usually has a sweet tooth, does not smokes, and physical exertion is less.Diagnosis at that time: 2 type glycosurias
Disease, doctor gives antidiabetic drug (metformin) Drug therapy, because after taking medicine, metformin has stimulation to stomach, has a stomach upset, clothes
Just disable with this medicine first quarter moon, do not carry out rule Drug therapy afterwards.Thereafter fasting glucose 8.8mmol/L is looked in outpatient service, after the meal
2 hours blood glucose 12.3mmol/L.Diagnosis: type 2 diabetes mellitus.Remedy measures: glucose-lowering treatment uses this detailed description of the invention to provide
Formula cookies carries out Diet Therapy, each 50g, and (patient reduces every day on the basis of normal diet staple food amount to eat 2 every day
100g, does not use any hypoglycemic medicine), when the most edible 15 days, check fasting glucose 7.8mmol/L of patient, 2 is little after the meal
Time blood glucose 9 mmol/L;Using this formula cookies to treat first quarter moon the most continuously, fasting glucose 6.7 mmol/L of patient, 2 is little after the meal
Time blood glucose 7.5mmol/L, after be continuing with again this formula cookies treatment first quarter moon, fasting glucose 5.7mmol/L of present patient,
2 hours blood glucose 6.9 mmol/L after the meal, at this moment weak the and blurred vision shape of patient is completely eliminated.Drop through the dietetic therapies of 45 days
Sugar is satisfactory for result, and patient is the most satisfied, in the case of not taking medicine and having an injection, glycemic control is up to standard.Patient blood glucose is stable
After Zheng Chang, in accordance with above Dietotherapy method, as the life style of long-term health preserving, health is the most healthy, and glucostasis is normal.
Zhao, female, 35 years old, company clerk, at certain hospital admission, tell on October 4th, 2015: often feel xerostomia,
Double weakness of the lower extremitiess 1 year.Usually there are polyphagia, polydipsia, polyuria symptom.Previously remove medical history without special other.Laboratory examination finds blood glucose liter
Height, fasting glucose 9.4 mmol/L, after the meal 2 hours blood glucose 13.4 mmol/L.Glycolated hemoglobin 10.3%, measuring blood pressure, BP
125/85 mmHg.Patient diagnosis: type 2 diabetes mellitus.Because patient is the most sick, it is not desired to psychologically take medicine and have an injection, still wants to
Hyperglycemia is controlled to normally, under the guidance of doctor, just have employed dietetic therapy Combined with Exercise Therapy.Dietetic therapy uses this concrete
Formula cookies described in embodiment, each 50g, every day 2 times, (patient reduces every day on the basis of normal diet staple food amount
100g, does not use any hypoglycemic medicine), when the most edible 20 days, check fasting glucose 8.3mmol/L of patient, 2 is little after the meal
Time blood glucose 12.6 mmol/L, use the most continuously this Formula Diets treat 20 days, fasting glucose 7.1 mmol/L of patient, after the meal
2 hours blood glucose 9.4mmol/L, are continuing with again the dietetic therapy of this formula 20 days, fasting glucose 6.1mmol/L of patient, and 2 is little after the meal
Time blood glucose 7.8 mmol/L, at this moment the xerostomia of patient, double weakness of the lower extremities symptom are completely eliminated, measuring blood pressure, BP122/82 mmHg.
Preferable through the dietetic therapy hypoglycemic effects of 60 days, patient is the most satisfied, eats the formula cookies that the present invention provides, often the most always
Secondary 50g, every day 1-2 time, the fasting glucose of patient and after the meal 2 hours blood glucoses are always stable within normal range.
Detailed description of the invention 3
The cookies of a kind of early prevention and treatment type 2 diabetes mellitus unlike detailed description of the invention 1 includes the raw material of following weight proportioning:
Radix Et Rhizoma Fagopyri Tatarici 20g, Semen vignae sinensis 40g, Semen sojae atricolor 18g, roasting fragrant Semen Sesami Nigrum 18g, Fructus Tritici aestivi 80g, Rhizoma Polygonati 13g, Folium Mori 8g, Rhizoma Dioscoreae 20g,
Fructus Momordicae charantiae 20 g, Radix Puerariae 15g, Rhizoma Polygonati Odorati 10, water are appropriate.Its manufacture method is with detailed description of the invention 1.
The model case of the formula cookies that edible this detailed description of the invention 2 is provided has as follows:
History, female, 64 years old, retired employees, at certain hospital admission, state: because diet is irregular before 3 years on February 16th, 2016, food
Measuring slightly larger and inclined sweet food, discontinuity occurs weak, xerostomia, and toe is numb, and urine is increased, and previously has hypertension history 6 years.Outpatient service
Check and find that blood glucose raises, fasting glucose 8.5 1mmol/L, after the meal 2 hours blood glucose 12.6mmol/L.Measuring blood pressure, BP 140/
95 mmHg.Patient diagnosis:, type 2 diabetes mellitus, diabetic peripheral sexually transmitted disease (STD) become;, hypertension.Remedy measures: adopt
With:, blood sugar lowering use the formula cookies dietetic therapy that this detailed description of the invention provides, each 50g, every day, 2 times (patient was every
It reduces 100g on the basis of normal diet staple food amount, does not use any hypoglycemic medicine);, blood pressure lowering use valsartan
80mg/ time, 1 times/day;, improve neuropathy use alpha-lipoic acid injection associating vitamin B12..Patient makes medication continuously
Treat when coordinating dietetic therapy 20 days, check fasting glucose 7.1mmol/L of patient, 2 hours blood glucose 10.2 mmol/L after the meal, survey blood
Pressure, BP130/90mmHg, use medication to coordinate dietetic therapy to treat 20 days the most continuously, fasting glucose 6.5mmol/L of patient, after the meal 2
Hours blood glucose 7.5mmol/L, it is weak, and toe is numb, and urine is increased symptom and substantially disappeared, measuring blood pressure, BP125/88mmHg,
After disabling neurotrophy medicine, it is continuing with again the dietetic therapy of this formula 20 days, fasting glucose 5.6mmol/L of present patient, meal
Rear 2 hours blood glucose 6.6 mmol/L, glycolated hemoglobin 6.7 %, measuring blood pressure, measuring blood pressure, BP118/75 mmHg.At this moment suffer from
Person's is weak, and toe is numb, and urine is increased symptom and is completely eliminated, measuring blood pressure, BP118/75 mmHg.Drop through the dietetic therapies of 60 days
Sugar, satisfactory for result, patient is the most satisfied.
Detailed description of the invention 4
The cookies of a kind of early prevention and treatment type 2 diabetes mellitus unlike detailed description of the invention 1 includes the raw material of following weight proportioning:
Radix Et Rhizoma Fagopyri Tatarici 25g, Semen vignae sinensis 45g, Semen sojae atricolor 15g, roasting fragrant Semen Sesami Nigrum 20g, Fructus Tritici aestivi 80g, Rhizoma Polygonati 15g, Folium Mori 9g, Rhizoma Dioscoreae 30g,
Fructus Momordicae charantiae 25 g, Radix Puerariae 12g, Rhizoma Polygonati Odorati 12, water are appropriate.Its manufacture method is with detailed description of the invention 1.
The model case of the formula cookies that edible this detailed description of the invention 2 is provided has as follows:
Female Yuan, 50 years old, office worker, before 1 year, after work strain and fatigue, malaise, xerostomia, sometimes head occur
Dizzy, dim eyesight symptom.On March 17th, 2016 arrives certain hospital admission, checks and finds that blood glucose raises, fasting glucose 8 .9mmol/L,
2 hours blood glucose 12.4 mmol/L after the meal.Measuring blood pressure, BP 125/80 mmHg.Previously without special except medical history.Patient diagnosis: 2 type sugar
Urine disease.Patient claims: be not desired to take medicine and have an injection, and still wants to hyperglycemia be controlled to normal range, doctor's wanting according to patient
Method, have employed dietetic therapy Combined with Exercise Therapy.Dietetic therapy uses the formula cookies that this detailed description of the invention provides, and starts to eat:
50g every time, every day, 2 times (patient reduced 100g every day on the basis of normal diet staple food amount, does not use any hypoglycemic medicine
), when the most edible 20 days, fasting glucose 7.3mmol/L of inspection patient, 2 hours blood glucose 10.3 mmol/L after the meal, the most continuously
Using this Formula Diets to treat 20 days, fasting glucose 6.4 mmol/L of patient, 2 hours blood glucose 8.4mmol/L, continues again after the meal
Continuous use this formula dietetic therapy 20 days, fasting glucose 5.7mmol/L of patient, 2 hours blood glucose 7.9 mmol/L, at this moment suffers from after the meal
The malaise of person, xerostomia, dizzy, dim eyesight symptom is completely eliminated, measuring blood pressure, BP120/80 mmHg.Drop through the dietetic therapies of 60 days
Hypoglycemic effect is preferable, and later patient the most often eats the cookies that this detailed description of the invention provides, and the blood glucose of patient is always stable
Within normal range.
The above, the only present invention preferably detailed description of the invention, but protection scope of the present invention is not limited thereto,
Any those familiar with the art in the technical scope that the invention discloses, according to technical scheme and
Inventive concept equivalent or change in addition, all should contain within protection scope of the present invention.
Claims (4)
1. the cookies of an early prevention and treatment type 2 diabetes mellitus, it is characterised in that include the raw material of following weight proportioning: Radix Et Rhizoma Fagopyri Tatarici 18-
30g, Semen vignae sinensis 30-50g, Semen sojae atricolor 15-20g, roasting fragrant Semen Sesami Nigrum 15-20g, Fructus Tritici aestivi 80g, Rhizoma Polygonati 9-15g, Folium Mori 6-9 g,
Rhizoma Dioscoreae 15-30g, Fructus Momordicae charantiae 15-25 g, Radix Puerariae 6-15g, Rhizoma Polygonati Odorati 6-12g, water are appropriate.
The cookies of a kind of early prevention and treatment type 2 diabetes mellitus the most according to claim 1, it is characterised in that include following weight
The raw material of proportioning: Radix Et Rhizoma Fagopyri Tatarici 30g, Semen vignae sinensis 50g, Semen sojae atricolor 20g, roasting fragrant Semen Sesami Nigrum 20g, Fructus Tritici aestivi 80g, Rhizoma Polygonati 10g, Folium Mori
6g, Rhizoma Dioscoreae 30g, Fructus Momordicae charantiae 25 g, Radix Puerariae 10g, Rhizoma Polygonati Odorati 6, water are appropriate.
3. the manufacture method of the cookies of an early prevention and treatment type 2 diabetes mellitus, it is characterised in that comprise the steps:
(1) Radix Et Rhizoma Fagopyri Tatarici, Semen vignae sinensis, by featured, Semen sojae atricolor is according to aforementioned proportion proportioning, and is respectively washed, is soaked in clear cold boiled water
In water, Radix Et Rhizoma Fagopyri Tatarici immersion 1 hour, Semen vignae sinensis immersion 3 hours, Semen sojae atricolor soak 8 hours;
(2) Rhizoma Polygonati, by selected mistake, Folium Mori, Rhizoma Dioscoreae, Fructus Momordicae charantiae, Radix Puerariae, Rhizoma Polygonati Odorati prepare in proportion, and wrap use with medicated diet bag
Refrigerant boiled water is soaked in porcelain earth pot 50 minutes, the most boiled, and first intense fire water opens rear exchange of notes fire, continues
Within 55 minutes, boil medicine into juice;
(3), boil medicine in step (2) water by firm boiled when, put into Semen sojae atricolor (10 g) and liquid medicine with decocting 20 minutes after, then
After placing into Semen vignae sinensis (25 g) same with liquid medicine pan-fried 15 minutes, it is finally putting into Radix Et Rhizoma Fagopyri Tatarici (15 g) with medicine juice with decocting 20 minutes, stops working
Except medicinal residues, pour out Radix Et Rhizoma Fagopyri Tatarici, Semen vignae sinensis, Semen sojae atricolor and medicine juice that first part of medicine is decocted;
(4), used medicinal residues in step (3) are placed again in porcelain earth pot, carry out again according to the method boiled medicine in step (2)
Secondary boil medicine, be sequentially added into the Semen sojae atricolor with step (3) equivalent, Semen vignae sinensis, Radix Et Rhizoma Fagopyri Tatarici by the method that step (3) is same simultaneously, obtain
Radix Et Rhizoma Fagopyri Tatarici, Semen vignae sinensis, Semen sojae atricolor and the medicine juice that two parts of medicines are decocted, is then combined in one by Radix Et Rhizoma Fagopyri Tatarici, Semen vignae sinensis, Semen sojae atricolor and medicine juice that twice medicine is decocted
Rise;
(5), with wall-breaking machine, Radix Et Rhizoma Fagopyri Tatarici, Semen vignae sinensis, Semen sojae atricolor and the medicine juice that twice medicine is decocted is carried out broken wall treatment 3 minutes, obtain breaking cellular wall
After the food medicine juice mixed serum containing the function of blood sugar reduction factor;
(6), selected Semen Sesami Nigrum is baked out fragrance;
(7) after, the Semen Sesami Nigrum of roasting perfume (or spice) and Fructus Tritici aestivi powder raw material being proportionally mixed and added to the breaking cellular wall that step (5) obtains
In food medicine juice mixed serum containing the function of blood sugar reduction factor, (between each raw material, allocation ratio is Radix Et Rhizoma Fagopyri Tatarici 3 by weight
Part, Semen vignae sinensis 5 parts, black bean powder 2 parts, wheat germ powder 8 parts, roasting fragrant Semen Sesami Nigrum 2 parts), stir and become flour mixed with adulterants agglomerate;
(8) the flour mixed with adulterants agglomerate with function of blood sugar reduction, by step (7) obtained, die mould become fritter cookies and point every part be
10g, dries, vacuum packaging.
The manufacture method of the cookies of a kind of early prevention and treatment type 2 diabetes mellitus the most according to claim 2, it is characterised in that step
Suddenly baking Semen Sesami Nigrum in (6) and use baking box, its operating process is as follows:, Semen Sesami Nigrum is put baking tray floating, does not get wet;, etc.
Furnace temperature is raised to 150 DEG C and places into baking;, to take chopsticks to turn over (preventing adustion) every 3~5 minutes when baking, close when 10 minutes
Fall baking box, use the remaining temperature of baking box slowly to dry (wanting variable interval to turn over);, Semen Sesami surface is golden yellow the most permissible.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610775180.XA CN106212614A (en) | 2016-08-31 | 2016-08-31 | A kind of cookies of early prevention and treatment type 2 diabetes mellitus and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610775180.XA CN106212614A (en) | 2016-08-31 | 2016-08-31 | A kind of cookies of early prevention and treatment type 2 diabetes mellitus and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106212614A true CN106212614A (en) | 2016-12-14 |
Family
ID=58071983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610775180.XA Pending CN106212614A (en) | 2016-08-31 | 2016-08-31 | A kind of cookies of early prevention and treatment type 2 diabetes mellitus and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106212614A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107095291A (en) * | 2017-05-03 | 2017-08-29 | 杨涵 | It is a kind of to activate the natural meals that islet cells promotes metabolism of blood glucose |
CN108669174A (en) * | 2018-07-16 | 2018-10-19 | 陈帅 | It is a kind of to reach therapeutic purposes glucose-lowering biscuit by integration of drinking and medicinal herbs |
CN109699706A (en) * | 2018-12-24 | 2019-05-03 | 浙江旺林生物科技有限公司 | A kind of healthy biscuit |
CN114052225A (en) * | 2020-08-05 | 2022-02-18 | 广东云药科技有限公司 | Formula of nutritional powder for diabetic patients and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101258923A (en) * | 2008-01-23 | 2008-09-10 | 陈君 | Multi-dimensional multifunctional health care battercake |
CN103005411A (en) * | 2011-09-21 | 2013-04-03 | 王芳 | Blood-sugar-reucing herbal cuisine gruel and making method thereof |
CN104146259A (en) * | 2014-08-26 | 2014-11-19 | 安徽溪瑞食品有限公司 | Health-care flour for diabetes patients and preparation method thereof |
-
2016
- 2016-08-31 CN CN201610775180.XA patent/CN106212614A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101258923A (en) * | 2008-01-23 | 2008-09-10 | 陈君 | Multi-dimensional multifunctional health care battercake |
CN103005411A (en) * | 2011-09-21 | 2013-04-03 | 王芳 | Blood-sugar-reucing herbal cuisine gruel and making method thereof |
CN104146259A (en) * | 2014-08-26 | 2014-11-19 | 安徽溪瑞食品有限公司 | Health-care flour for diabetes patients and preparation method thereof |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107095291A (en) * | 2017-05-03 | 2017-08-29 | 杨涵 | It is a kind of to activate the natural meals that islet cells promotes metabolism of blood glucose |
CN108669174A (en) * | 2018-07-16 | 2018-10-19 | 陈帅 | It is a kind of to reach therapeutic purposes glucose-lowering biscuit by integration of drinking and medicinal herbs |
CN109699706A (en) * | 2018-12-24 | 2019-05-03 | 浙江旺林生物科技有限公司 | A kind of healthy biscuit |
CN114052225A (en) * | 2020-08-05 | 2022-02-18 | 广东云药科技有限公司 | Formula of nutritional powder for diabetic patients and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103355555A (en) | Feed for laying hen in egg-laying peak stage and preparation method thereof | |
CN101797326B (en) | Chinese materia medica preparation for treating borborygmus diarrhoea and preparation method thereof | |
CN103417837B (en) | Medlar health preserving cream of a kind of medicine-food two-purpose and preparation method thereof | |
CN103405728B (en) | A kind of Chinese medicine composition for the treatment of climacteric syndrome and preparation method thereof | |
CN105233100A (en) | Drink for treating diabetes and preparation method thereof | |
CN106212614A (en) | A kind of cookies of early prevention and treatment type 2 diabetes mellitus and preparation method thereof | |
CN106360286A (en) | Nutritive composition as well as preparation method and application thereof | |
CN104758839A (en) | Traditional Chinese medicinal pill for treating tension headache and preparation method thereof | |
CN103736072B (en) | Medicine of a kind for the treatment of of allergic rhinitis and preparation method thereof | |
CN101366914B (en) | Medicament for tumour restraint, anti-hunger, detoxication, reinforcing phylactic power and preparation method | |
CN109395028A (en) | A kind of Ge Jingjia ginseng wine formula and preparation method preventing, treating three high diseases | |
CN109481589A (en) | A kind of preparation method of the toxin expelling anti-cancer capsule for treating lung cancer and dietotherapy anticancer | |
CN103463625B (en) | Nourish heart nutritional preparation of enriching blood | |
CN105028995A (en) | Mixed dog food and preparation method thereof | |
CN106177477A (en) | A kind of health composition for blood sugar lowering, blood fat reducing and blood pressure lowering | |
CN104544084B (en) | A kind of health food for diabetics | |
CN105727253A (en) | Liver protecting and toxin removing composition for prevention and treatment of liver diseases and relevant metabolic diseases and preparation method thereof | |
CN114748603A (en) | Medicine-food homologous composition for preventing and treating new coronavirus pneumonia variation or compound yang and application | |
CN103392855A (en) | Spleen-tonifying and blood-controlling health-care tea paste and preparation method thereof | |
CN103340991B (en) | Oral liquid for nursing diabetics and preparation method thereof | |
CN106036384A (en) | Health preservation porridge suitable for diabetes patients to eat and making method of health preservation porridge | |
CN102552743A (en) | Medicinal composition for treating diabetes and preparation method thereof | |
CN104857372A (en) | Drink for treating type 2 diabetes mellitus combined with hypertension and preparation method of drink | |
CN104524358A (en) | Pills for adjuvant treatment of iron-deficiency anemia and preparation method thereof | |
CN103272147A (en) | Traditional Chinese medicine preparation for curing vomiting of pregnancy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 457001 Room 201, unit 1, building 8, Kangping New District, Renqiu Road, Hualong District, Puyang City, Henan Province Applicant after: Shi Huamin Address before: 457000 No.3, unit 1, building 28, Kangping community, No.124, middle section of Daqing Road, Puyang City, Henan Province Applicant before: Shi Huamin |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161214 |